Plantaricin NC8 αβ exerts potent antimicrobial activity against Staphylococcus spp. and enhances the effects of antibiotics.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
27 02 2020
27 02 2020
Historique:
received:
12
09
2019
accepted:
13
02
2020
entrez:
29
2
2020
pubmed:
29
2
2020
medline:
15
12
2020
Statut:
epublish
Résumé
The use of conventional antibiotics has substantial clinical efficacy, however these vital antimicrobial agents are becoming less effective due to the dramatic increase in antibiotic-resistant bacteria. Novel approaches to combat bacterial infections are urgently needed and bacteriocins represent a promising alternative. In this study, the activities of the two-peptide bacteriocin PLNC8 αβ were investigated against different Staphylococcus spp. The peptide sequences of PLNC8 α and β were modified, either through truncation or replacement of all L-amino acids with D-amino acids. Both L- and D-PLNC8 αβ caused rapid disruption of lipid membrane integrity and were effective against both susceptible and antibiotic resistant strains. The D-enantiomer was stable against proteolytic degradation by trypsin compared to the L-enantiomer. Of the truncated peptides, β1-22, β7-34 and β1-20 retained an inhibitory activity. The peptides diffused rapidly (2 min) through the bacterial cell wall and permeabilized the cell membrane, causing swelling with a disorganized peptidoglycan layer. Interestingly, sub-MIC concentrations of PLNC8 αβ substantially enhanced the effects of different antibiotics in an additive or synergistic manner. This study shows that PLNC8 αβ is active against Staphylococcus spp. and may be developed as adjuvant in combination therapy to potentiate the effects of antibiotics and reduce their overall use.
Identifiants
pubmed: 32107445
doi: 10.1038/s41598-020-60570-w
pii: 10.1038/s41598-020-60570-w
pmc: PMC7046733
doi:
Substances chimiques
Anti-Bacterial Agents
0
Bacteriocins
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
3580Commentaires et corrections
Type : ErratumIn
Références
Assis, L. M., Nedeljkovic, M. & Dessen, A. New strategies for targeting and treatment of multi-drug resistant Staphylococcus aureus. Drug resistance updates: reviews and commentaries in antimicrobial and anticancer chemotherapy 31, 1–14, https://doi.org/10.1016/j.drup.2017.03.001 (2017).
doi: 10.1016/j.drup.2017.03.001
Fridkin, S. K. et al. Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 36, 429–439, https://doi.org/10.1086/346207 (2003).
doi: 10.1086/346207
Kali, A. Antibiotics and bioactive natural products in treatment of methicillin resistant Staphylococcus aureus: A brief review. Pharmacognosy reviews 9, 29–34, https://doi.org/10.4103/0973-7847.156329 (2015).
doi: 10.4103/0973-7847.156329
pubmed: 26009690
pmcid: 26009690
Lowy, F. D. Antimicrobial resistance: the example of Staphylococcus aureus. The Journal of clinical investigation 111, 1265–1273, https://doi.org/10.1172/JCI18535 (2003).
doi: 10.1172/JCI18535
pubmed: 12727914
pmcid: 12727914
Cotter, P. D., Ross, R. P. & Hill, C. Bacteriocins - a viable alternative to antibiotics? Nature reviews. Microbiology 11, 95–105, https://doi.org/10.1038/nrmicro2937 (2013).
doi: 10.1038/nrmicro2937
pubmed: 23268227
pmcid: 23268227
Czaplewski, L. et al. Alternatives to antibiotics-a pipeline portfolio review. The Lancet infectious diseases 16, 239–251, https://doi.org/10.1016/S1473-3099(15)00466-1 (2016).
doi: 10.1016/S1473-3099(15)00466-1
pubmed: 26795692
pmcid: 26795692
Varella Coelho, M. L., de Souza Duarte, A. F. & do Carmo de Freire Bastos, M. Bacterial Labionin-Containing Peptides and Sactibiotics: Unusual Types of Antimicrobial Peptides with Potential Use in Clinical Settings (a Review). Current topics in medicinal chemistry 17, 1177–1198, https://doi.org/10.2174/1568026616666160930144809 (2017).
doi: 10.2174/1568026616666160930144809
pubmed: 27697045
pmcid: 27697045
Diep, D. B., Straume, D., Kjos, M., Torres, C. & Nes, I. F. An overview of the mosaic bacteriocin pln loci from Lactobacillus plantarum. Peptides 30, 1562–1574, https://doi.org/10.1016/j.peptides.2009.05.014 (2009).
doi: 10.1016/j.peptides.2009.05.014
pubmed: 19465075
pmcid: 19465075
Maldonado, A., Ruiz-Barba, J. L. & Jiménez-Díaz, R. Purification and Genetic Characterization of Plantaricin NC8, a Novel Coculture-Inducible Two-Peptide Bacteriocin from Lactobacillus plantarum NC8. Appl. Environ. Microbiol 69, 383–389, https://doi.org/10.1128/AEM.69.1.383-389.2003 (2003).
Yang, S. C., Lin, C. H., Sung, C. T. & Fang, J. Y. Antibacterial activities of bacteriocins: application in foods and pharmaceuticals. Frontiers in microbiology 5, 241, https://doi.org/10.3389/fmicb.2014.00241 (2014).
doi: 10.3389/fmicb.2014.00241
pubmed: 24904554
pmcid: 24904554
Ekblad, B. et al. Structure-Function Analysis of the Two-Peptide Bacteriocin Plantaricin EF. Biochemistry. 55, 5106–5116, https://doi.org/10.1021/acs.biochem.6b00588 (2016).
doi: 10.1021/acs.biochem.6b00588
pubmed: 27538436
pmcid: 27538436
Oppegard, C., Kjos, M., Veening, J. W., Nissen-Meyer, J. & Kristensen, T. A putative amino acid transporter determines sensitivity to the two-peptide bacteriocin plantaricin JK. Microbiology Open 5, 700–708, https://doi.org/10.1002/mbo3.363 (2016).
doi: 10.1002/mbo3.363
pubmed: 27150273
pmcid: 27150273
Bruno, B. J., Miller, G. D. & Lim, C. S. Basics and recent advances in peptide and protein drug delivery. Therapeutic delivery 4, 1443–1467, https://doi.org/10.4155/tde.13.104 (2013).
doi: 10.4155/tde.13.104
pubmed: 24228993
pmcid: 24228993
Bengtsson, T. et al. Dual action of bacteriocin PLNC8 alphabeta through inhibition of Porphyromonas gingivalis infection and promotion of cell proliferation. Pathogens and disease 75, https://doi.org/10.1093/femspd/ftx064 (2017).
Khalaf, H. et al. Antibacterial effects of Lactobacillus and bacteriocin PLNC8 alphabeta on the periodontal pathogen Porphyromonas gingivalis. BMC microbiology 16, 188, https://doi.org/10.1186/s12866-016-0810-8 (2016).
doi: 10.1186/s12866-016-0810-8
pubmed: 27538539
pmcid: 27538539
Zhao, X., Zhen, Z., Wang, X. & Guo, N. Synergy of a combination of nisin and citric acid against Staphylococcus aureus and Listeria monocytogenes. Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment 34, 2058–2068, https://doi.org/10.1080/19440049.2017.1366076 (2017).
doi: 10.1080/19440049.2017.1366076
Field, D., R, O. C., Cotter, P. D., Ross, R. P. & Hill, C. In Vitro Activities of Nisin and Nisin Derivatives Alone and In Combination with Antibiotics against Staphylococcus Biofilms. Frontiers in microbiology 7, 508, https://doi.org/10.3389/fmicb.2016.00508 (2016).
doi: 10.3389/fmicb.2016.00508
pubmed: 27148197
pmcid: 27148197
Bastos Mdo, C., Coelho, M. L. & Santos, O. C. Resistance to bacteriocins produced by Gram-positive bacteria. Microbiology 161, 683–700, https://doi.org/10.1099/mic.0.082289-0 (2015).
doi: 10.1099/mic.0.082289-0
pubmed: 25406453
pmcid: 25406453
Hellmark, B., Unemo, M., Nilsdotter-Augustinsson, A. & Soderquist, B. Antibiotic susceptibility among Staphylococcus epidermidis isolated from prosthetic joint infections with special focus on rifampicin and variability of the rpoB gene. Clin. Microbiol Infect 15, 238–244, https://doi.org/10.1111/j.1469-0691.2008.02663.x (2009).
doi: 10.1111/j.1469-0691.2008.02663.x
pubmed: 19196261
pmcid: 19196261
Nilsdotter-Augustinsson, A., Koskela, A., Ohman, L. & Soderquist, B. Characterization of coagulase-negative staphylococci isolated from patients with infected hip prostheses: use of phenotypic and genotypic analyses, including tests for the presence of the ica operon. European journal of clinical microbiology & infectious diseases: official publication of the European Society of Clinical Microbiology 26, 255–265, https://doi.org/10.1007/s10096-007-0281-9 (2007).
doi: 10.1007/s10096-007-0281-9
Bangham, A. D., Standish, M. M. & Watkins, J. C. Diffusion of univalent ions across the lamellae of swollen phospholipids. Journal of molecular biology 13, 238–252, https://doi.org/10.1016/s0022-2836(65)80093-6 (1965).
doi: 10.1016/s0022-2836(65)80093-6
pubmed: 5859039
pmcid: 5859039
Wang, Q., Chen, Z. & Xu, Y. The relationship between onset of labour and concentration of hyaluronic acid and estradiol to progesterone ratio. Zhonghua Fu Chan Ke Za Zhi 31, 477–479 (1996).
pubmed: 9275440
pmcid: 9275440
Mukherjee, S. et al. Accelerated molecular dynamics simulation analysis of MSI-594 in a lipid bilayer. Phys Chem Chem Phys 19, 19289–19299, https://doi.org/10.1039/c7cp01941f (2017).
doi: 10.1039/c7cp01941f
pubmed: 28702543
pmcid: 28702543
Marques, C. et al. Effects of antibiotics on biofilm and unattached cells of a clinical Staphylococcus aureus isolate from bone and joint infection. Journal of medical microbiology 64, 1021–1026, https://doi.org/10.1099/jmm.0.000125 (2015).
doi: 10.1099/jmm.0.000125
pubmed: 26297246
pmcid: 26297246
Blaser, M. Antibiotic overuse: Stop the killing of beneficial bacteria. Nature 476, 393–394, https://doi.org/10.1038/476393a (2011).
doi: 10.1038/476393a
pubmed: 21866137
pmcid: 21866137
Rogers, K. L., Fey, P. D. & Rupp, M. E. Coagulase-negative staphylococcal infections. Infectious disease clinics of North America 23, 73–98, https://doi.org/10.1016/j.idc.2008.10.001 (2009).
doi: 10.1016/j.idc.2008.10.001
Heilmann, C., Ziebuhr, W. & Becker, K. Are coagulase-negative staphylococci virulent? Clin. Microbiol Infect 25, 1071–1080, https://doi.org/10.1016/j.cmi.2018.11.012 (2019).
doi: 10.1016/j.cmi.2018.11.012
Otto, M. Staphylococcus epidermidis–the ‘accidental’ pathogen. Nature reviews. Microbiology 7, 555–567, https://doi.org/10.1038/nrmicro2182 (2009).
doi: 10.1038/nrmicro2182
pubmed: 19609257
pmcid: 19609257
Mashaly, G. E. & El-Mahdy, R. H. Vancomycin heteroresistance in coagulase negative Staphylococcus blood stream infections from patients of intensive care units in Mansoura University. Hospitals, Egypt. Annals of clinical microbiology and antimicrobials 16, 63, https://doi.org/10.1186/s12941-017-0238-5 (2017).
doi: 10.1186/s12941-017-0238-5
pubmed: 28927452
pmcid: 28927452
Zhang, Y. et al. Synergy of ambroxol with vancomycin in elimination of catheter-related Staphylococcus epidermidis biofilm in vitro and in vivo. Journal of infection and chemotherapy: official journal of the Japan Society of Chemotherapy 21, 808–815, https://doi.org/10.1016/j.jiac.2015.08.017 (2015).
doi: 10.1016/j.jiac.2015.08.017
Corr, S. C. et al. Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118. Proc. Natl. Acad. Sci. USA 104, 7617–7621, https://doi.org/10.1073/pnas.0700440104 (2007).
doi: 10.1073/pnas.0700440104
Wang, G., Li, X. & Wang, Z. APD2: the updated antimicrobial peptide database and its application in peptide design. Nucleic acids research 37, D933–937, https://doi.org/10.1093/nar/gkn823 (2009).
doi: 10.1093/nar/gkn823
Rollema, H. S., Kuipers, O. P., Both, P., de Vos, W. M. & Siezen, R. J. Improvement of solubility and stability of the antimicrobial peptide nisin by protein engineering. Applied and environmental microbiology 61, 2873–2878 (1995).
doi: 10.1128/AEM.61.8.2873-2878.1995
Johnsen, L., Fimland, G., Eijsink, V. & Nissen-Meyer, J. Engineering increased stability in the antimicrobial peptide pediocin PA-1. Applied and environmental microbiology 66, 4798–4802 (2000).
doi: 10.1128/AEM.66.11.4798-4802.2000
Hong, S. Y., Oh, J. E. & Lee, K. H. Effect of D-amino acid substitution on the stability, the secondary structure, and the activity of membrane-active peptide. Biochemical pharmacology 58, 1775–1780 (1999).
doi: 10.1016/S0006-2952(99)00259-2
Wade, D. et al. All-D amino acid-containing channel-forming antibiotic peptides. Proc. Natl. Acad. Sci. USA 87, 4761–4765 (1990).
doi: 10.1073/pnas.87.12.4761
Hamamoto, K., Kida, Y., Zhang, Y., Shimizu, T. & Kuwano, K. Antimicrobial activity and stability to proteolysis of small linear cationic peptides with D-amino acid substitutions. Microbiology and immunology 46, 741–749 (2002).
doi: 10.1111/j.1348-0421.2002.tb02759.x
Nagant, C. et al. Identification of peptides derived from the human antimicrobial peptide LL-37 active against biofilms formed by Pseudomonas aeruginosa using a library of truncated fragments. Antimicrobial agents and chemotherapy 56, 5698–5708, https://doi.org/10.1128/AAC.00918-12 (2012).
doi: 10.1128/AAC.00918-12
pubmed: 3486595
pmcid: 3486595
Chan, E. L., Harris, R. C. & Dalton, H. P. The effect of antibiotics on the cell morphology of Legionella pneumophila. Journal of medical microbiology 23, 149–154, https://doi.org/10.1099/00222615-23-2-149 (1987).
doi: 10.1099/00222615-23-2-149
Cushnie, T. P., O’Driscoll, N. H. & Lamb, A. J. Morphological and ultrastructural changes in bacterial cells as an indicator of antibacterial mechanism of action. Cellular and molecular life sciences: CMLS 73, 4471–4492, https://doi.org/10.1007/s00018-016-2302-2 (2016).
doi: 10.1007/s00018-016-2302-2
pubmed: 27392605
pmcid: 27392605
Sahu, K., Bansal, H., Mukherjee, C., Sharma, M. & Gupta, P. K. Atomic force microscopic study on morphological alterations induced by photodynamic action of Toluidine Blue O in Staphylococcus aureus and Escherichia coli. Journal of photochemistry and photobiology. B, Biology 96, 9–16, https://doi.org/10.1016/j.jphotobiol.2009.03.008 (2009).
doi: 10.1016/j.jphotobiol.2009.03.008
pubmed: 19423358
pmcid: 19423358
Koike, M., Iida, K. & Matsuo, T. Electron microscopic studies on mode of action of polymyxin. Journal of bacteriology 97, 448–452 (1969).
doi: 10.1128/JB.97.1.448-452.1969
Rabanal, F. et al. A bioinspired peptide scaffold with high antibiotic activity and low in vivo toxicity. Scientific reports 5, 10558, https://doi.org/10.1038/srep10558 (2015).
doi: 10.1038/srep10558
pubmed: 26024044
pmcid: 26024044
Greenwood, D. & O’Grady, F. Scanning electron microscopy of Staphyloccus aureus exposed to some common anti-staphylococcal agents. Journal of general microbiology 70, 263–270, https://doi.org/10.1099/00221287-70-2-263 (1972).
doi: 10.1099/00221287-70-2-263
pubmed: 4483215
pmcid: 4483215
Maria-Neto, S., de Almeida, K. C., Macedo, M. L. & Franco, O. L. Understanding bacterial resistance to antimicrobial peptides: From the surface to deep inside. Biochimica et biophysica acta 1848, 3078–3088, https://doi.org/10.1016/j.bbamem.2015.02.017 (2015).
doi: 10.1016/j.bbamem.2015.02.017
pubmed: 25724815
pmcid: 25724815
Collins, B., Curtis, N., Cotter, P. D., Hill, C. & Ross, R. P. The ABC transporter AnrAB contributes to the innate resistance of Listeria monocytogenes to nisin, bacitracin, and various beta-lactam antibiotics. Antimicrobial agents and chemotherapy 54, 4416–4423, https://doi.org/10.1128/AAC.00503-10 (2010).
doi: 10.1128/AAC.00503-10
pubmed: 20643901
pmcid: 20643901
McBride, S. M. & Sonenshein, A. L. Identification of a genetic locus responsible for antimicrobial peptide resistance in Clostridium difficile. Infect. Immun. 79, 167–176, https://doi.org/10.1128/IAI.00731-10 (2011).
doi: 10.1128/IAI.00731-10
pubmed: 20974818
pmcid: 20974818
Vadyvaloo, V. et al. Cell-surface alterations in class IIa bacteriocin-resistant Listeria monocytogenes strains. Microbiology 150, 3025–3033, https://doi.org/10.1099/mic.0.27059-0 (2004).
doi: 10.1099/mic.0.27059-0
pubmed: 15347760
pmcid: 15347760
Vadyvaloo, V., Hastings, J. W., van der Merwe, M. J. & Rautenbach, M. Membranes of class IIa bacteriocin-resistant Listeria monocytogenes cells contain increased levels of desaturated and short-acyl-chain phosphatidylglycerols. Applied and environmental microbiology 68, 5223–5230 (2002).
doi: 10.1128/AEM.68.11.5223-5230.2002
Tamma, P. D., Cosgrove, S. E. & Maragakis, L. L. Combination therapy for treatment of infections with gram-negative bacteria. Clinical microbiology reviews 25, 450–470, https://doi.org/10.1128/CMR.05041-11 (2012).
doi: 10.1128/CMR.05041-11
pubmed: 22763634
pmcid: 22763634
Worthington, R. J. & Melander, C. Combination approaches to combat multidrug-resistant bacteria. Trends in biotechnology 31, 177–184, https://doi.org/10.1016/j.tibtech.2012.12.006 (2013).
doi: 10.1016/j.tibtech.2012.12.006
pubmed: 23333434
pmcid: 23333434
Pletzer, D., Mansour, S. C. & Hancock, R. E. W. Synergy between conventional antibiotics and anti-biofilm peptides in a murine, sub-cutaneous abscess model caused by recalcitrant ESKAPE pathogens. PLoS pathogens 14, e1007084, https://doi.org/10.1371/journal.ppat.1007084 (2018).
doi: 10.1371/journal.ppat.1007084
pubmed: 29928049
pmcid: 29928049
Eckert, R. et al. Enhancement of antimicrobial activity against pseudomonas aeruginosa by coadministration of G10KHc and tobramycin. Antimicrobial agents and chemotherapy 50, 3833–3838, https://doi.org/10.1128/AAC.00509-06 (2006).
doi: 10.1128/AAC.00509-06
pubmed: 16940063
pmcid: 16940063
Mataraci, E. & Dosler, S. In vitro activities of antibiotics and antimicrobial cationic peptides alone and in combination against methicillin-resistant Staphylococcus aureus biofilms. Antimicrobial agents and chemotherapy 56, 6366–6371, https://doi.org/10.1128/AAC.01180-12 (2012).
doi: 10.1128/AAC.01180-12
pubmed: 23070152
pmcid: 23070152
Tevell, S., Claesson, C., Hellmark, B., Soderquist, B. & Nilsdotter-Augustinsson, A. Heterogeneous glycopeptide intermediate Staphylococcus epidermidis isolated from prosthetic joint infections. European journal of clinical microbiology & infectious diseases: official publication of the European Society of Clinical Microbiology 33, 911–917, https://doi.org/10.1007/s10096-013-2025-3 (2014).
doi: 10.1007/s10096-013-2025-3